According to Viracta Therapeutics's latest financial reports the company's current earnings (TTM) are -$45.34 M. In 2023 the company made an earning of -$51.06 M a decrease over its 2022 earnings that were of -$49.2 M.The earnings displayed on this page is the company's Pretax Income.